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ABSTRACT 
 
Cancer is recognized as global threat to human development and it was estimated that in 2030 there will be 22.2 
million new cases of cancer and 12.7 million cancer-related deaths worldwide. Herbal medicine plant till this day all 
over in the word is still the main source and one of the most important fields of traditional medicine agents to fight 
breast cancer. The usage of plants is still important because has its own beaviour advantages such as low toxicity, 
easy to get, cheap and has less side effect if it is used in a right. One of this plant that has been used as a traditional 
medicine is a Phaleria macrocarpa (Scheff) Boerl) also known as Mahkota Dewa from Papua island. It has been used 
traditionally for treatment of cancers in Indonesia and also to cure many diseases. The therapeutic effect of P. 
macrocarpa is related to its bioactive compounds contents. There are many reported compounds from P. macrocarpa, 
which are found, reported and published such as Icariside, phalerin, mangiferin, gallic acid, 29-Norcucurbitacin, 
gentiobioside and glucoside. All compounds reported above have already published as anticancer agents,where 
anticancer activity were detected and showed against Hela cells, leukemia cells, cervical cancer, breast cancer, and 
L1210 cells. Research on P. macrocarpa fruit and leaves merit have been done and published, however, there are very 
limited research on the linked correlation between the concentration of compounds and its the cytotoxicity  level. 
Because of that, research about correlation level of P. macrocarpa leaves extract still need to investigate to find the 
relationship between them in the goal to investigate alternative low cost herbal medicine agents to fight breast cancer 
especially useful for low income people. Cytotoxicity properties of samples against breast cancer cell lines was 
performed by using the MTT assay against MCF-7 cell line. The correlation between concentration of crude and 
cytotoxic activity was interpreted by statistical analyses. The study showed that P. macrocarpa.) leaves extracts 
showed cytoxicity activity against breast cancer MCF7 cell lines. Correlation between concentration of extract and 
cytotoxicity property (absorbance value) were founded in weak relationship (R = -0.37181). It could be effect of many 
different compounds in the P. macrocarpa leaves methanol extracts may cause the pharmacological interactions, so 
lower or higher concentration will be antagonistic effect on absorbance or cell viability.Further study on its 
mechanism pathway on revealing against breast cancer could be explored. Furthermore, the natural product derived 
from P. macrocarpa leaves extracts have potential use in cheap alternative agents against breast cancer. 
 




 Cancer is recognized as global threat to human development and it was estimated that in 2030 there 
will be 22.2 million new cases of cancer and 12.7 million cancer-related deaths worldwide (Bray et al., 
2012). In low and middle-income countries (LMIC) worldwide , where woman odds of survival in many 
low income countries, are as low as 10–25% (Sankaranarayanan,  2010) with more harsh consequences for 
women due to gender discrimination, stigma, and cultural taboos, which conspire to limit women’s choices 
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to seek care even when it is available (Ginsburg, 2013 ). In among women world-wide breast cancer 
is currently the leading cause of cancer incidence which accounts for nearly 1 in 4 cases of cancer, 
with 55% of cases occurring in more industrialized countries and 45% in less industrialized countries 
(Krieger, 2002). Estimated In 2008 there were an 1.38 million new cases accounting for 23% of all 
new cancer cases and 458,000 deaths from breast cancer (Ferlay et al., 2010), with consistently ranks the 
breast cancer as the most common cancer in women in most countries. In low- and middle-income 
countries, incidence of breast cancer is rising rapidly with economic development, which 
approximately half of new cases and close to 60% of deaths occur (Jin et al., 1999).   
Each year, more than 200,000 women are died from breast and cervical cancer which over 50% of 
deaths are from breast cancer and approximately 88% of deaths from cervical cancer occur in less 
developed regions, where gender discrimination and extreme poverty severely limit a woman’s choice to 
seek care (Ginsburg, 2013). In LMI countries health systems are overwhelmed with competing 
priorities, while providers of care are unprepared to deal with the growing epidemic of cancer and 
most women with cancer will face additional burdens as the need to attend to a her personal health 
crisis always outweighed by primary responsibilities to the family (Ginsburg, 2013).  In Indonesia 
more than 65% of Indonesian breast cancers were found already in late stage, with poor grade and 
with lymph nodes metastasis condition, therefore, research for study of clinicopathological features 
from Indonesian molecular subtypes need to be done, in order to determine more proper  management and 
prognosis (Widodo et al., 2013). 
There are several molecular subtypes of breast cancer with different biological behavior, 
epidemiological risk factor, natural histories, response against local and systemic treatment and also 
prognosis (Goldhirsch et al., 2011). Breast cancer is classified based on their molecular expression 
characteristics of ER, PR, Her-2 and Ki-67, an classified into subtype of luminal A, luminal B, Her-
2+ and triple negative subtypes/basaL-like (Onitilo et al., 2009), and In Indonesia molecular subtypes 
of breast cancers are still unknown (Widodo et al., 2014).  
In the recent times complementary and alternative medicine (CAM) is common use among 
breast cancer patient world wide, its impact on use is estimated to be between 48% and 70% in the 
United States (Nahleh, 2003). In a study of breast cancer patients showed that more common used 
CAM in broad modalities such as natural products, botanical supplements, special dietary methods 
(Greenlee et al., 2009), herbal remedies, and spiritual healing (Lee et al.,  2000). Definitions of CAM 
currently categorizes into five modalities: mind-body medicine (mind), manipulative and body-based 
practices (body), biologically based products (nature) include herbs/botanicals, probiotics, and high-
dose vitamins, energy medicine (energy), and whole medical systems (WMS)(Matsuno et al., 2012)  
 Source of natural product as sources of anti-oxidant coumpounds  from secondary metabolites 
to fight against disease is very broad area such as sponges (Zalilawati et al., 2015) and seaweeds from sea 
(Andriani et al., 2016), wetlands forest plant (Eldeen et al., 2016), coastal area plant (Andriani et al., 
2015), tropical forest plant (Mohamad et al., 2015; Andriani et al., 2005), ordinary plant (Andriani et 
al., 2008), bacteria (Radzi et al., 2015) and fungi (Andriani et al.,  2007).  
 Herbal medicine plant till this day all over in the word is still the main source and one of the 
most important fields of traditional medicine agents to fight breast cancer. The usage of plants is still 
important because has its own beaviour advantages such as low toxicity, easy to get, cheap and has 
less side effect if it is used in a right dose (Andriani et al., 2011). One of this plant that has been used 
as a traditional medicine  is a Phaleria macrocarpa (Scheff) Boerl)  also known as Mahkota Dewa 
from Papua island. It has been used traditionally for treatment of cancers in Indonesia and also to 
cure many diseases like lever, heart, diabetic, skin diseases, rheumatism, anti histamine, and lower 
the cholesterol level. This therapeutic effect is directly related to the antioxidant activity which are 
major contribution from its Phenolics contents (Heo et al., 2007: Jacobo, 2009). From the fruit, seed 
and leaves of P. macrocarpa  antioxidant activity and potencies has been reported (Lisdawati, 2006; 
Andriani, 2011) and phytochemical and biological activities investigation have been done 
(Purwantini, 2002).  
 The therapeutic effect of P. macrocarpa is related to its bioactive compounds contents. 
There are many reported compounds from P. macrocarpa have been found, reported and published 
such as icariside, phalerin, mangiferin (Oshimi ,2009), gallic acid (Faried, 2007), isomer of phalerin 
Amir et al. 
140                                                                                            Asian Journal For Poverty Studies 3(2): 138 - 145   
(Mae, 2005; Tambunan 2006), 29-Norcucurbitacin, together with its derivatives (Kurnia, 2008), 
gentiobioside and glucoside (Andriani, 2014). All compounds reported above have already published 
as anticancer agent, wich anticancer activity were detected and showed against Hela cells (Sumastuti, 
2002), leukemia cells (Lisdawati, 2006), cervical cancer (Mudahar, 2005), breast cancer (Harahap, 
2007), and L1210 cells (Winarno, 2009) .  
 Research on P. macrocarpa fruit and leaves merit have been done and published. However, 
there are very limited research on the correlation between the concentration of compounds  and its 
cytotoxicity level. Because of that, research about correlation level of P. macrocarpa leaves extract 
still need to investigate to find the relationship between them in the goal to investigate alternative 
low cost herbal medicine agents to fight breast cancer especially useful for low income people, thus, 




Sample collection and extraction 
 
Samples of P. macrocarpa  leaves were collected from the City Bengkulu area, Sumatera Island, 
Indonesia. Firstly, the leaves samples were sliced and air-dried for 14 days. The dried leaves were 
ground into powder. Crude extract was obtained by maceration using methanol, i.e. the samples of 
dry powder (500g) were soaked in methanol for 5 days, filtrated, and concentrated by using a rotary 
evaporator to obtain a concentrated methanol extract. The actives crude fraction extract were be continued 
for further Cytotoxicity/ MTT assay. 
 
Cytotoxicity/ MTT assay from crude extract 
 
 Cytotoxicity properties of samples against breast cancer cell lines were performed using the 
MTT assay.  Cytotoxicity activity from P. macrocarpa leaves crude extract were determined by 
MTT (Microtetrazolium ) assay against MCF-7 (hormone-dependent breast carcinoma cells ) cell 
line. MTT or 3-(4, 5-dimethylthiazol-2-yl) 2, 5-diphenyl tetrazolium bromide assay was prepared as 
previously described method was used by Mosmann (1983) with some modifications. The MTT 
assay relies on the production of a colored formazan by the action of mitochondrial enzymes on 
MTT. The MTT assay test was performed using sterile flat-bottomed 96 well plates. About 100 µL of 
exponentially grown MCF-7 cell suspensions was seeded, harvested, counted and inoculated at a 
density of 5 × 103 cells/well in into three 96-well micro-titre plates. The plate was incubated at 37 °C 
in 5 % (v/v) CO2 incubator for 24 hours. After 24 hours, 100 µL of the prepared concentrations of P. 
macrocarpa. leaves crude extract  (60; 30; 15; 7,5; 3,75; 1,875; 0,9375; and 0 μg/mL) of each sample 
was added into each well and the plates were further incubated for 72 hours at 37 °C in 5 % (v/v) 
CO2 .  
The assay at each concentration was performed in triplicates and untreated cells were 
designated as control. After72 hours, the viability of cells was measured by the amount of blue 
formazan crystals formed after 20 µL fresh MTT solution (5 mg/mL in PBS) was added to each well. 
The plate then was incubated for four hours at 37 °C, 5% CO2. Subsequently, 170 µL of medium was 
removed and 100 µL of Dimethyl sulphoxide (DMSO) was added into each well and mix thoroughly 
by pipettes (10-20 times) in order to dissolve the blue formazan crystals. The plate was left for 30 
minutes before measuring the Optical Density (OD) by using ELISA reader at 595 nm reference 
wavelengths. The activity was expressed as IC50 (the concentration that inhibits 50% of cell 
growth). Cytotoxic activity was expressed as fifty-percent Inhibition concentration (IC50), i.e. the 
concentration that yields 50% inhibition of the treated cells compared to untreated cell control. 
Sample exhibiting cytotoxic index LC50 < 30 μg/mL, was considered to have significant cytotoxic 
activity. Cytotoxic activity was expressed as fifty-percent Inhibition concentration (IC50), i.e. the 
concentration that yields 50% inhibition of the treated cells compared to untreated cell control. The 
criteria of non toxic activity for the IC50 value of the sample if it is yielded more than 30 μg/ mL. 
(Andriani et al., 2011), and if sample which exhibit cytotoxic index LC50 < 30 μg/mL, were 
considered to have significant cytotoxic activity  
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Data collected from MTT assay was statistically analyzed using correlation method to 
measure the degree of association between the crude concentration and cytotoxic.  
 




In this research, MCF7 cell lines was used to predict of the toxicity. Result in Table 1 show 
that absorbance from MTT assay test having IC50 value was counted. Table 1 also shows that  
methanol extract from P. macrocarpa.) leave exhibited the lowest absorbance in MCF7 cells 
produced by MTT assay at concentrations around 15 µg/ml. Lowering or increasing the extract 
concentration from 15 µg/ml, however, would improve the absorbance and, thus, reducing MCF7 cell 
viability. Correlation between the extract concentration and the absorbance was relatively low (R = -
0.37181). These results suggested that various compounds contained in the P. macrocarpa. leave 
methanol extracts might pharmacologically interact resulting an antagonistic effect on absorbance or 
cell viability.  
 Figure 1 depicts 50% inhibitory activity (IC50) value of P. macrocarpa.) leave methanol 
extracts was obtained  approximately at 15 μg/ml and considered as toxic concentration. Andriani et al. 
(2011) reported that cytotoxicity property of sample with the IC50 value less than 30µg/mL was 
considered as toxic. In this study, methanol extract from P. macrocarpa. leave exhibited a toxic 
activity against breast cancer MCF 7 cell line and offered further investigation. Nevertheless, the 
presence of antioxidants compound in the P. macrocarpa. leave extracts may potentially reduce cell 
number, since reactive oxygen radicals play an important role in carcinogenesis like breast cancer 
like MCF7. 
 Figure 1 also shows that lowering the concentration of methanol extract of P. macrocarpa. leave 
could substantially reduce the viability of  MCF7 cells, even  at concentrations lower than 30µg/mL. 
Further study is needed to elucidate the effect of lower concentrations (less than its IC50 value, ±15 
Table. 1.  Correlation between concentration and absorbance of each MCF7 cell lines for cytotoxici-
ty assay of Phaleria macrocarpa (Scheff) Boerl.) leaves extracts. 
Concentrations 
(µg/mL) Absorbance Mean Correlation 
60 0,298, 0,230, 0,222, 0,213, 0,222, 0,250, 
0,233, 0,213, 0,260, 0,229, 0,229, 0,236 0,23625 
 R = -0.37181 
  
30 
0,208, 0,192, 0,239, 0,335, 0,168, 0,177, 
0,168, 0,163, 0,230, 0,198, 0,155, 0,155 0,1990 
15 0,160, 0,106, 0,211, 0,153, 0,144, 0,245, 
0,277, 0,140, 0,382, 0,266, 0,148, 0,138 0,1975 
7,5 0,190, 0,220, 0,217 :0,180, 0,190, 0,327, 
0,287, 0,217, 0,242, 0,377, 0,180, 0,307 0,2445 
3,75 0,197, 0,283, 0,188, 0,204, 0,197, 0,263, 
0,241, 0,188, 0,221, 0,286, 0,204 0,227 0,224917 
1,875 0,229, 0,303, 0,290, 0,275, 0,229, 0,281, 
0,308, 0,275, 0,341, 0,334, 0,204, 0,204 
0,27275 
0,9375 0,213, 0,249, 0,262, 0,286, 0,213,  0,312, 
0,217, 0,217, 0,310, 0,240, 0,224,  0,224 
0,24725 
0 0,186, 0,194, 0,215, 0,305, 0,305, 0,247, 
0,282, 0,282, 0,261, 0,265, 0,307, 0,236 
0,257083 
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µg/mL) on the cell morphology to confirm this activity. In this study, P. macrocarpa. leave 
methanol extracts showed high cytotoxicity property against MCF- 7 cell lines, but with the 
antagonistic weak correlation. This antagonistic effect might be resulted from the interaction 
among chemical constituents in P. macrocarpa. leave extracts, as reported by Golden et al. (2009), 
where anti-carcinogenic and antitumor effects of individual compound could be blocked in presence 
the other compounds. Therefore, the characteristics of each chemical compound should be identified 
to determine their cytotoxicity against breast cancer (MCF7) cell lines.  
 Previous study reported that P. macrocarpa. leave contain abundant of various compounds, 
such as alkaloid, flavonoid, polifenol, and tannin. Similarly, two new phenolic compounds, vis., 4',6-
dihydroxy,4-methoxybenzophenone-2-O-β-D-gentiobioside and 4',6-
dihydroxy,4methoxybenzophenone-2-O-β-D-glucoside  had been isolated from P. macrocarpa. leave 
methanol extract by Andriani et al. (2014) and  showed antioxidant activity by 66 and 69 %, whose 
could be correlated to its bioactivities property especially against breast cancer cell line ( MCF7). 
Anticancer properties of phenolic and flavonoids compounds had been widely reported (Yao et al., 
2011; Fresco et al., 2010). Moreover,  a linear correlation between phenolics or flavonoids content 
and antioxidant activity was reported by Ghasemzadeh et al. (2010) and various biological activities 





The study showed that methanol P. macrocarpa. leave extracts had a toxicity activity against 
breas cancer  MCF7 cell lines. Presence of phenolic antioxidant compounds in the extracts might 
have an important role in reducing cell number. Further study is needed to explore mechanism 
pathway of the extract in combating the breast cancer and, in turn, to provide more affordable 
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Figure 1. Cytotoxicity Property of P. macrocarpa leaves methanol extracts against MCF-7 
cells compare to the control H2O2  
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